ERBB2 and pancreatic neoplasm: Moertl et al. have compared the radiosensitization of pancreatic cancer cells through the HDAC inhibitor SAHA and the multi target inhibitor CUDC-101, which, besides HDAC, also targets EGFR and HER2 (135).